Vaxcyte Posts $1.99 Q3 GAAP Loss Per Share, 15 Cents Better Than Estimate
Photo: TokenPost
In results announced Nov. 4, Vaxcyte posted a third-quarter GAAP loss of $1.99 per share, 15 cents better than the estimate, while cash, cash equivalents and investments totaled $2,264.4 million at Sept. 30. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
